Role of cannabinoid receptor in the brain as it relates to drug reward

Japanese Journal of Pharmacology

Volumn 84, Issue 3, 2000, Pages 229-236

  Yamamoto, T ^a   Takada, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antinociceptive effect; Cannabinoid receptor; Discriminative stimulus property; Drug reward system

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENOSINE DERIVATIVE; ALCOHOL; AMPHETAMINE; ANANDAMIDE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS; CP 55490; DOPAMINE DERIVATIVE; FENCLONINE; METHYLPHENIDATE; METIROSINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NALTREXONE; NICOTINE; OPIATE; OPIATE ANTAGONIST; OPIATE DERIVATIVE; OPIATE RECEPTOR; PHENCYCLIDINE; RIMONABANT; SEROTONIN ANTAGONIST; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIA; ANTINOCICEPTION; BRAIN; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; NEUROTRANSMISSION; NONHUMAN; PAIN; REVIEW; REWARD;

EID: 0034535311     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.84.229     Document Type: Review

References (54)

1. Cannabinoid compounds and signal transduction mechanisms
2. Structure of cannabinoid receptor and functional expression of the cloned cDNA
3. Molecular characterization of a peripheral receptor for cannabinoid
4. The effects of cannabinoids on the brain
5. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
6. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
7. Discovery and characterization of endogenous cannabinoids
8. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase
9. Cannabinoid transmission and pain perception
10. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: Antagonist effects of SR 141716A
11. Pain modulation by release of the endogenous cannabinoid anandamide
12. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
13. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
14. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors
15. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis
16. 9-tetrahydrocannabinol
17. 9-tetrahydrocannabinol and morphine in the spinal cord
18. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
19. 9-tetrahydrocannabinol-tolerant rats
20. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
21. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine
22. Modulation of rat brain cannabinoid receptors after chronic morphine treatment
23. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice
24. Assessment of the abuse potentiality of morphine-like drugs: Methods used in man
25. Drug discrimination studies in humans - A review of methodologies
26. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication
27. 9-tetrahydrocannabinol discrimination in rats
28. 9-tetrahydrocannabinol in rhesus monkeys
29. 9-tetrahydrocannabinol: Mechanistic studies
30. Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats
31. 9-THC and its interaction with naltexone and catecholamine blockers in rats
32. 9-tetrahydrocannabinol in man
33. Discriminative stimulus and subjective effects of smoked marijuana in humans
34. 9-tetrahydrocannabinol
35. A map of the rat mesencephalon for electrical self-stimulation
36. Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behavior
37. Nigral transplants reinnervating the dopamine-depleted neostriatum can sustian intracranial self-stimulation
38. Self-administration of and behavioral dependence on drugs
39. Intravenous self-administration of drugs in rats
40. 9-tetrahydrocannabinol in rhesus monkeys
41. Failure to obtain 'cannabis-directed behavior' and abstinence syndrome in rats chronically treated with cannabis sativa extracts
42. Reluctance of rats to drink hashish suspensions: Free-choice and forced consumption, and the effects of hypothalamic stimulation
43. Cannabinoid transmission and reward-related events
44. Cannabis and phencyclidine self-administered by animals
45. 9-tetrahydrocannabinol (THC) in rhesus monkeys
46. 9-tetrahydrocannabinol by rats
47. Cocaine-seeking produced by experimenter-administered injections: Dose-effect relationships in rats
48. Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
49. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane
50. Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption
51. 9-tetrahydrocannabinol and social context on marijuana self-administration in humans
52. 9-Tetrahydrocannabinol content and human marijuana self-administration
53. 9-THC and smoked marijuana in humans
54. Factors influencing marijuana self-administration by humans